NSC | Compound | Enrichment | Correlation |
---|---|---|---|
NSC 659390 | Null | 0.013789112253851 | 0.51425291 |
NSC 661832 | Null | 0.013789112253851 | 0.48206817 |
NSC 665771 | Null | 0.013789112253851 | 0.17568536 |
NSC 669146 | 6,9-Epoxy-2H-1,4-dioxacyclodeca[cd]pentalene-2,7(4aH)-dione, 2a,3,5,6,11a,11b-hexahydro-3-hydroxy-2a,6,10-trimethyl-3-(1-methylethenyl)-, [2aS-(2aR*,3S*,4aR*,6S*,10Z,11aS*,11bS*)]- | 0.013789112253851 | 0.46734084 |
NSC 681279 | 5-Phenyl-4-oxo-oxadiazolo(5,4-c)quinolin-3-N-oxide (furoxan) | 0.013789112253851 | 0.53856905 |
NSC 684901 | Null | 0.013789112253851 | 0.3900157 |
NSC 255111 | 19-Formylgeldanamycin N-piperidinoimine | 0.0171490505199913 | 0.46296299 |
NSC 282159 | EN 589 | 0.0171490505199913 | 0.36873801 |
NSC 301477 | 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-4-O-methyl-.alpha.-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(hydroxyacetyl)-1-methoxy-, (8S-cis)- | 0.0171490505199913 | 0.35822308 |
NSC 328785 | ANTINEOPLASTIC-328785 | 0.0171490505199913 | 0.32575298 |